Carvedilol
- 1,2,3,9-Tetrahydro-4H-carbazol-4-one (CAS No.15128-52-6)
- 4-Hydroxy carbazole (CAS No. 52602-39-8)
- 4-(2,3-Epoxy propoxy) carbazole (CAS No. 51997-51-4)
- 2-(2-Methoxy phenoxy) ethyl amine (CAS No.1836-62-0) /HCL (CAS No.18366-20)
- N-[2-(2-Methoxy phenoxy) ethyl] benzyl amine (CAS No.3246-03-5)/ HCL (CAS No.120606-08-8)
Citalopram Hydrobromide / Escitalopram oxalate
- 4-[(4'-Dimethyl amino)-1-(4"-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile hydrobromide (CAS No. 103146-26-5)
- Citalopram base (CAS No. 59729-33-8)
- 1-(4'-Fluoro phenyl)-1,3-dihydro iso benzofuran-5-carbonitrile (CAS No. 64169-67-1)
- 5-Bromo-1-(3-dimethyl amino propyl) -1-(4'fluoro phenyl)-1,3-dihydro isobenzofuran oxalate
Sertraline hydrochloride
- Sertraline mandelate (CAS No. 79559-97-0)
- Racemic Sertraline hydrochloride
Ondansetron hydrochloride dihydrate
- 9-Methyl-1,2,3,9-tetra hydro 4H carbazol-4-one (Cas No. 27387-31-1)
- 3-[(NN-Dimethyl amino) methyl]-9-methyl-1,2,3,9-tetra hydro 4H-carbazol-4-one hydrochloride (CAS No. 119812-29-2).
- Ondansetron base (99614-02-5)
Duloxetine intermediates
- 3-Dimethyl amino-1- (2-thienyl)-1-propanone hydrochloride
- RS-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine(CAS No.116817-84-6)
- S(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine ( CAS no. 132335-44-5)
- RS-N,N- Dimethyl-3-(1-Naphthalenyloxy)-3-(2-thienyl)-1-propanamine oxalate
- S-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-thienyl)-1-propanamine oxalate (CAS No.132335-47-8)
- (+) -N-Methyl -3-(1-naphthyloxy)-3-(2-thienyl) propanamine hydrochloride
Other products
- N-Methyl-1-Naphthyl methyl amine hydrochloride (CAS No. 65473-13-4) (for Terbinafin and Butanafin)
- (Alpha-meta hydroxy phenyl) ethyl dimethyl amine hydrochloride (for Rivastigmine)
- Oxatomide dihydrochloride
- 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]-propyl]-1,3-dihydro-2H-benzimidazol-2-one (Oxatomide) (60607-34-3)
- Oxatomide monohydrate
Products under development
Voriconazole
Rivastigmine tartrate
Valsartan
The products will not be offered to the countries where the valid patents exist
For Contact: Dr. Giridhar Thota, Managing Director, Ph: 0091-40-55844664 Fax: 0091-40-55848998 email : info@shodhana.com , web site: shodhana.com
The products will not be offered to the countries where the valid patents exist |